{"database": "lobbying", "table": "lobbying_activities", "rows": [[1368658, "cba1728e-aa32-4ae7-8662-46dda2081cc0", "Q1", "HPS GROUP, LLC", 400323518, "RARE DISEASE THERAPEUTICS", 2013, "first_quarter", "HCR", "To provide waivers of product and facility user fees for small companies developing low-revenue orphan drugs", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2013-04-02T14:33:24.310000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1368658"], "units": {}, "query_ms": 0.9908530046232045, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}